Detalles de la búsqueda
1.
Recurrence Patterns and Long-term Results After Induction Chemotherapy, Chemoradiotherapy, and Curative Surgery in Patients With Locally Advanced Esophageal Cancer.
Ann Surg
; 269(1): 83-87, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28742685
2.
Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial.
Lancet
; 386(9998): 1049-56, 2015 Sep 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275735
3.
Impact of CT convolution kernel on robustness of radiomic features for different lung diseases and tissue types.
Br J Radiol
; 94(1120): 20200947, 2021 Apr 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33544646
4.
Preselection of robust radiomic features does not improve outcome modelling in non-small cell lung cancer based on clinical routine FDG-PET imaging.
EJNMMI Res
; 11(1): 79, 2021 Aug 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-34417899
5.
Quantification of the spatial distribution of primary tumors in the lung to develop new prognostic biomarkers for locally advanced NSCLC.
Sci Rep
; 11(1): 20890, 2021 10 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34686719
6.
Intense therapy in patients with locally advanced esophageal cancer beyond hope for surgical cure: a prospective, multicenter phase II trial of the Swiss Group for Clinical Cancer Research (SAKK 76/02).
Onkologie
; 33(5): 222-8, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20502056
7.
Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
Lancet Oncol
; 10(8): 785-93, 2009 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-19604722
8.
Radiomics Feature Activation Maps as a New Tool for Signature Interpretability.
Front Oncol
; 10: 578895, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33364192
9.
Comparison of robust to standardized CT radiomics models to predict overall survival for non-small cell lung cancer patients.
Med Phys
; 47(9): 4045-4053, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32395833
10.
Multimodal Treatment in Operable Stage III NSCLC: A Pooled Analysis on Long-Term Results of Three SAKK trials (SAKK 16/96, 16/00, and 16/01).
J Thorac Oncol
; 14(1): 115-123, 2019 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30267838
Resultados
1 -
10
de 10
1
Próxima >
>>